Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02947971 · ClinicalTrials.gov registry record · NA

Pilot Study for TCE Imaging of the Esophagus Using an OFDI Capsule With a Compact Imaging System

A NA study of Barrett's Esophagus, sponsored by Massachusetts General Hospital.

Recruiting
Registry status
NA
Development phase
120
Enrollment target
1
Study location

NCT02947971 is a NA study of Barrett's Esophagus that is actively recruiting participants, run by Massachusetts General Hospital. The registered enrollment target is 120 participants, below the 519-participant average among 22 other Barrett's Esophagus trials with a reported enrollment target (77% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02947971, a NA study of Barrett's Esophagus, is actively recruiting participants, sponsored by Massachusetts General Hospital.

RECRUITING
Registry status
NA
Development phase
120 participants
Enrollment target
1
Study location

Study Summary

The goal of this research is to test a distal scanning capsule and a compact redesigned version of the OFDI imaging system in healthy and BE participants to assess ease of use, safety and feasibility in preparation for its use in a multicenter clinical trial.

Conditions Studied

Interventions

  • DEVICE Experimental OFDI Imaging

Study Locations (1)

Massachusetts

  • Massachusetts General hospital - Boston

Trial Details

FieldValue
Enrollment Target 120 participants
Start Date 2016-04-15
Est. Completion 2028-12
Phase NA

Sponsor

Massachusetts General Hospital

2,032 total trials

What the Registry Record Tells You About NCT02947971

The ClinicalTrials.gov registry entry for NCT02947971 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 519-participant average among 22 other Barrett's Esophagus trials with a reported enrollment target (77% lower). The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Barrett's Esophagus appearing as the primary indexed condition, and to 1 intervention - of which Experimental OFDI Imaging is the first listed.

NCT02947971 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT02947971 about?

NCT02947971 is a clinical study titled "Pilot Study for TCE Imaging of the Esophagus Using an OFDI Capsule With a Compact Imaging System". The goal of this research is to test a distal scanning capsule and a compact redesigned version of the OFDI imaging system in healthy and BE participants to assess ease of use, safety and feasibility in preparation for its use in a multicenter clinical trial.

What is the current status of trial NCT02947971?

This trial is currently recruiting. It is a NA study. The enrollment target is 120 participants. The study started on 2016-04-15. Estimated completion is 2028-12.

What conditions does trial NCT02947971 study?

This clinical trial studies the following conditions: Barrett's Esophagus.

What interventions are being tested in trial NCT02947971?

The interventions under investigation include: Experimental OFDI Imaging (DEVICE).

Who is sponsoring clinical trial NCT02947971?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02947971 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Barrett's Esophagus

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.